Metraipolis › archive › dc_fbc294ea868e

Evaluating use of disease-modifying therapies for multiple sclerosis using claims data — Europe PMC PMID:41884669

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41884669
DOI: 10.3389/frhs.2026.1714922
License (as archived): solo-consultazione
Archived: 2026-11-04T21:19:49.390Z
SHA-256 of the archived text: 9ca3c386b52428603919470cfb8fa6cb31f87a09c32c5f45aa902e5c2d337408
Stable URL of this page: https://metraipolis.com/documento/dc_fbc294ea868e

How to cite

Evaluating use of disease-modifying therapies for multiple sclerosis using claims data — Europe PMC PMID:41884669 — Europe PMC (en), https://europepmc.org/article/MED/41884669 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbc294ea868e (Metraipolis archive dc_fbc294ea868e, sha256 9ca3c386b52428603919470cfb8fa6cb31f87a09c32c5f45aa902e5c2d337408)

BibTeX

@misc{dcfbc294ea868e,
  title = {Evaluating use of disease-modifying therapies for multiple sclerosis using claims data — Europe PMC PMID:41884669},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41884669},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbc294ea868e; sha256 9ca3c386b52428603919470cfb8fa6cb31f87a09c32c5f45aa902e5c2d337408},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41884669. Agents can read the archived copy with the MCP tool read_document.